Pasquini S, Contri C, Merighi S, Gessi S, Borea PA, Varani K, et al
Possible Side Effects Ipamorelin is generally well-tolerated in preclinical and limited human research studies, with a favorable safety profile compared to earlier growth hormone releasing peptides
Monocytes and macrophages: developmental pathways and tissue homeostasis
(Gaby, A.R., 2002
Microvascular and macrovascular complications of diabetes
However, we do not fully understand why these aging hallmarks occur in the first place, and therefore there have been no proven solutions via human randomized clinical trials to improve or correct aging hallmarks in aging humans. The aging hallmarks that improved are mitochondrial dysfunction, altered intercellular communication, nutrient sensing, loss of proteostasis, genomic instability, cellular senescence and stem cell fatigue